Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs for Endometrial Repair in IVF Failure
NCT03166189Phase 2Completed
- Sponsor
- D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
- Start
- Dec 2017
- Primary completion
- Mar 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow derived mesenchymal stromal cells in Uterine Factor Infertility (UFI), Asherman syndrome (IUA), sponsored by D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology. Started Dec 2017; status: completed.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
Uterine Factor Infertility (UFI)Asherman syndrome (IUA)
Beyond the preview
Go deeper on NCT03166189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03166189.